PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,881,120 | -27.5% | 1,475,711 | -2.7% | 0.00% | – |
| Q2 2023 | $5,356,087 | +14.1% | 1,517,305 | -0.1% | 0.00% | – |
| Q1 2023 | $4,693,531 | -27.6% | 1,518,942 | -1.0% | 0.00% | – |
| Q4 2022 | $6,486,874 | +47.0% | 1,533,540 | -17.6% | 0.00% | – |
| Q3 2022 | $4,414,000 | -18.6% | 1,862,167 | -2.2% | 0.00% | – |
| Q2 2022 | $5,425,000 | -44.3% | 1,903,137 | -43.7% | 0.00% | – |
| Q1 2022 | $9,733,000 | -0.1% | 3,379,684 | +5.5% | 0.00% | – |
| Q4 2021 | $9,741,000 | -56.7% | 3,204,237 | -0.1% | 0.00% | -100.0% |
| Q3 2021 | $22,485,000 | -20.1% | 3,207,661 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $28,144,000 | -6.6% | 3,065,764 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $30,138,000 | -2.0% | 3,100,594 | +3.5% | 0.00% | 0.0% |
| Q4 2020 | $30,738,000 | +3.0% | 2,996,015 | +1.3% | 0.00% | 0.0% |
| Q3 2020 | $29,839,000 | -3.2% | 2,957,405 | +0.0% | 0.00% | 0.0% |
| Q2 2020 | $30,834,000 | +29.7% | 2,956,296 | +5.0% | 0.00% | 0.0% |
| Q1 2020 | $23,766,000 | -6.1% | 2,815,883 | -2.6% | 0.00% | 0.0% |
| Q4 2019 | $25,298,000 | -16.9% | 2,891,336 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $30,427,000 | -4.1% | 2,826,487 | +13.2% | 0.00% | 0.0% |
| Q2 2019 | $31,741,000 | -67.3% | 2,497,164 | -0.3% | 0.00% | -75.0% |
| Q1 2019 | $97,120,000 | +79.0% | 2,503,753 | -6.1% | 0.00% | +33.3% |
| Q4 2018 | $54,250,000 | -54.9% | 2,665,886 | +1.6% | 0.00% | -40.0% |
| Q3 2018 | $120,316,000 | -18.8% | 2,624,101 | +4.7% | 0.01% | -28.6% |
| Q2 2018 | $148,211,000 | -8.1% | 2,505,710 | +5.7% | 0.01% | -12.5% |
| Q1 2018 | $161,258,000 | -31.6% | 2,369,714 | -0.6% | 0.01% | -27.3% |
| Q4 2017 | $235,763,000 | +8.5% | 2,385,036 | +31.4% | 0.01% | 0.0% |
| Q3 2017 | $217,305,000 | +35.8% | 1,814,643 | -0.9% | 0.01% | +37.5% |
| Q2 2017 | $159,973,000 | +146.7% | 1,830,342 | +5.0% | 0.01% | +100.0% |
| Q1 2017 | $64,856,000 | +35931.1% | 1,743,418 | +29605.5% | 0.00% | – |
| Q4 2016 | $180,000 | -57.0% | 5,869 | -6.1% | 0.00% | -100.0% |
| Q3 2016 | $419,000 | +544.6% | 6,248 | +189.0% | 0.00% | – |
| Q2 2016 | $65,000 | -27.0% | 2,162 | -28.4% | 0.00% | – |
| Q1 2016 | $89,000 | -33.1% | 3,018 | +77.4% | 0.00% | – |
| Q4 2015 | $133,000 | -83.8% | 1,701 | -84.4% | 0.00% | -100.0% |
| Q3 2015 | $822,000 | -60.3% | 10,906 | -38.5% | 0.00% | -66.7% |
| Q2 2015 | $2,070,000 | +1124.9% | 17,733 | +2369.8% | 0.00% | – |
| Q1 2015 | $169,000 | -92.6% | 718 | -94.1% | 0.00% | -100.0% |
| Q4 2014 | $2,299,000 | -44.4% | 12,145 | -30.0% | 0.00% | -50.0% |
| Q3 2014 | $4,138,000 | +140.4% | 17,345 | -33.5% | 0.01% | +100.0% |
| Q2 2014 | $1,721,000 | -36.4% | 26,085 | +0.4% | 0.00% | -25.0% |
| Q1 2014 | $2,705,000 | +18.5% | 25,973 | +17.8% | 0.00% | 0.0% |
| Q4 2013 | $2,283,000 | +7510.0% | 22,053 | +3887.9% | 0.00% | – |
| Q3 2013 | $30,000 | +20.0% | 553 | 0.0% | 0.00% | – |
| Q2 2013 | $25,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |